Outlook of various diagnostics and nanodiagnostic techniques for COVID-19

被引：0
作者：
Preethi M. [1 ]
Roy L. [1 ]
Lahkar S. [1 ]
Borse V. [1 ]
机构：
[1] NanoBioSens Lab, Department of Medical Devices, National Institute of Pharmaceutical Education & Research (NIPER) Hyderabad, Telangana, Hyderabad
来源：
Biosensors and Bioelectronics: X | 2022年 / 12卷
关键词：
COVID-19; pandemic; Nanobiosensors; Nanodiagnostics; Nanoparticles; POC devices; SARS-CoV-2;
D O I：
10.1016/j.biosx.2022.100276
中图分类号：
学科分类号：
摘要：
The sudden outbreak of the coronavirus disease 2019 (COVID-19) pandemic has brought to the fore the existing threat of disease-causing pathogens that affect public health all over the world. It has left the best healthcare systems struggling to contain the spread of disease and its consequences. Under challenging circumstances, several innovative technologies have emerged that facilitated quicker diagnosis and treatment. Nanodiagnostic devices are biosensing platforms developed using nanomaterials such as nanoparticles, nanotubes, nanowires, etc. These devices have the edge over conventional techniques such as reverse transcription-polymerase chain reaction (RT-PCR) because of their ease of use, quicker analysis, possible miniaturization, and scope for use in point-of-care (POC) treatment. This review discusses the techniques currently used for COVID-19 diagnosis, emphasizing nanotechnology-based diagnostic devices. The commercialized nanodiagnostic devices in various research and development stages are also reviewed. The advantages of nanodiagnostic devices over other techniques are discussed, along with their limitations. Additionally, the important implications of the utility of nanodiagnostic devices in COVID-19, their prospects for future development for use in clinical and POC settings, and personalized healthcare are also discussed. © 2022 The Author(s)
引用
收藏
相关论文
共 137 条
  • [61] Jiao J., Duan C., Xue L., Liu Y., Sun W., Xiang Y., DNA nanoscaffold-based SARS-CoV-2 detection for COVID-19 diagnosis, Biosens. Bioelectron., 167, (2020)
  • [62] Joung J., Ladha A., Saito M., Segel M., Bruneau R., Huang M.-L.W., Kim N.-G., Yu X., Li J., Walker B.D., Greninger A.L., Jerome K.R., Gootenberg J.S., Abudayyeh O.O., Zhang F., Point-of-care testing for COVID-19 using SHERLOCK diagnostics, medRxiv Prepr. Serv. Heal. Sci., (2020)
  • [63] Kaur J., Srivastava R., Borse V., Recent advances in point-of-care diagnostics for oral cancer, Biosens. Bioelectron., 178, (2021)
  • [64] Kim H., Park M., Hwang J., Kim J.H., Chung D.R., Lee K., sung, Kang M., Development of label-free colorimetric assay for MERS-CoV using gold nanoparticles, ACS Sens., 4, pp. 1306-1312, (2019)
  • [65] Kim H.S., Abbas N., Shin S., A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores, Biosens. Bioelectron., 177, (2021)
  • [66] Konwar A.N., Borse V., Current status of point-of-care diagnostic devices in the Indian healthcare system with an update on COVID-19 pandemic, Sensors Int, 1, (2020)
  • [67] Kreier F., Deltacron: the story of the variant that wasn't, Nature, 602, (2022)
  • [68] Kumar N., Shetti N.P., Jagannath S., Aminabhavi T.M., Electrochemical sensors for the detection of SARS-CoV-2 virus, Chem. Eng. J., 430, (2022)
  • [69] Lamb L.E., Bartolone S.N., Ward E., Chancellor M.B., Rapid detection of novel coronavirus (COVID19) by reverse transcription-loop-mediated isothermal amplification, SSRN Electron. J., (2020)
  • [70] Lang K., Deltacron: is there a new variant at large, and should we worry? [WWW document], Med. News Today, (2022)
234567891011